INS and early-onset autosomal dominant Alzheimer disease: Analysis of the most common pathways targeted by these drugs was Alzheimer’s disease (10), Olfactory Transduction (10), Insulin Signaling (5), Phosphatidylinositol Signaling System (2) and Long-Term Potentiation (1).